Proteomic analysis revealed that VHL-restored tumors express reduced levels of proteins associated with ccRCC progression and immunosuppression, including components of MHC class I processing and PD-1 signaling. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.